39
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

ORCID Icon, , , , , , , & ORCID Icon show all
Pages 329-339 | Received 14 Feb 2024, Accepted 21 Jun 2024, Published online: 02 Jul 2024